Consolidated Statement Of Comprehensive Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7601173

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
682,000,000 JPY
682,000,000 JPY
682,000,000 JPY
4,290,000,000 JPY
682,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
406,000,000 JPY
Remeasurements of defined benefit plans, net of tax
121,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
164,000,000 JPY
Other comprehensive income
692,000,000 JPY
Comprehensive income
4,982,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
4,982,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.